Volume-based growth tumor kinetics as a prognostic biomarker for patients with EGFR mutant lung adenocarcinoma undergoing EGFR tyrosine kinase inhibitor therapy: a case control study

Những quyển sách tương tự

• The impact of smoking status on radiologic tumor progression patterns and response to epidermal growth factor receptor (EGFR)-tyrosine kinase inhibitors in lung adenocarcinoma with activating EGFR mutations
  Bằng: Cha, Yoon Ki, et al.
  Được phát hành: (2016)
• Efficacy and Safety of Afatinib for EGFR-mutant Non-small Cell Lung Cancer, Compared with Gefitinib or Erlotinib
  Bằng: Kim, Youjin, et al.
  Được phát hành: (2019)
• Analysis of the benefit of sequential cranial radiotherapy in patients with EGFR mutant non-small cell lung cancer and brain metastasis
  Bằng: Byeon, Seonggyu, et al.
  Được phát hành: (2016)
• Treatment and Outcomes of Metastatic Non-Small-Cell Lung Cancer Harboring Uncommon EGFR Mutations: Are They Different from Those with Common EGFR Mutations?
  Bằng: Jung, Hyun Ae, et al.
  Được phát hành: (2020)
• Comprehensive evaluation of the clinical utility of plasma EGFR test in non-small cell lung cancer patients with acquired resistance to first-line EGFR inhibitors
  Bằng: Kim, Hongsik, et al.
  Được phát hành: (2021)